Fate Therapeutics Inc. buy Barclays PLC
Start price
27.02.24
/
50%
€6.42
Target price
27.02.25
€9.22
Performance (%)
-81.86%
End price
28.02.25
€1.16
Summary
This prediction ended on 28.02.25 with a price of €1.16. The BUY prediction by Barclays_PLC for Fate Therapeutics Inc. performed very badly with a performance of -81.86%. Barclays_PLC has a follow-up prediction for Fate Therapeutics Inc. where he still thinks Fate Therapeutics Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fate Therapeutics Inc. | 12.048% | 12.048% | -78.879% |
| iShares Core DAX® | 1.097% | 4.456% | 31.213% |
| iShares Nasdaq 100 | -0.089% | 4.218% | 8.410% |
| iShares Nikkei 225® | 5.046% | 5.461% | 2.669% |
| iShares S&P 500 | 0.416% | 3.910% | 6.692% |
Comments by Barclays_PLC for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target raised by analysts at Barclays PLC from $6.00 to $10.00. They now have an "overweight" rating on the stock.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.86
14.05.25
14.05.25
€1.79
14.05.26
14.05.26
25.64%
23.07.25
23.07.25
